Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114675) titled 'Henagliflozin for the Treatment of Patients with T2DM and CKD: A Real-World, Multicenter Case Registry Study' on Dec. 16, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The 2nd Affiliated Hospital of Chongqing Medical University
Condition:
Patients with Type 2 Diabetes Mellitus (T2DM) complicated by Chronic Kidney Disease (CKD)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2024-06-24
Target Sample Size: Observation group:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=234574
Disclaimer: ...